InsiderTrades.com logo
Is Starlink Set For The Largest IPO In History?
From Paradigm Press   |   Ad
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!
Click here now for the urgent details.
John Adam Zangerle net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

John Zangerle Biography and Net Worth

VP of STERIS
Currently, John Adam Zangerle holds the position of Secretary, Senior Vice President & General Counsel at STERIS Plc (Ireland) and Co-Managing Director at Herotron E-Beam Service GmbH and Secretary & Director at STERIS Ltd. (both are subsidiaries of STERIS Plc (Ireland)).

He is also on the board of 6 other companies.

Mr. Zangerle previously was Secretary, Vice President & General Counsel at STERIS Corp.

What is John Adam Zangerle's net worth?

The estimated net worth of John Adam Zangerle is at least $5.80 million as of June 15th, 2022. Mr. Zangerle owns 27,936 shares of STERIS stock worth more than $5,796,441 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Zangerle may own. Additionally, Mr. Zangerle receives an annual salary of $718,450.00 as VP at STERIS. Learn More about John Adam Zangerle's net worth.

How old is John Adam Zangerle?

Mr. Zangerle is currently 57 years old. There are 7 older executives and no younger executives at STERIS. The oldest executive at STERIS is Ms. Julia K. Madsen, Senior Vice President of Life Sciences, who is 59 years old. Learn More on John Adam Zangerle's age.

What is John Adam Zangerle's salary?

As the VP of STERIS plc, Mr. Zangerle earns $718,450.00 per year. There are 3 executives that earn more than Mr. Zangerle. The highest earning executive at STERIS is Mr. Daniel A. Carestio, President, CEO & Director, who commands a salary of $1,590,000.00 per year. Learn More on John Adam Zangerle's salary.

How do I contact John Adam Zangerle?

The corporate mailing address for Mr. Zangerle and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on John Adam Zangerle's contact information.

Has John Adam Zangerle been buying or selling shares of STERIS?

John Adam Zangerle has not been actively trading shares of STERIS during the last ninety days. Most recently, John Adam Zangerle sold 2,659 shares of the business's stock in a transaction on Wednesday, June 15th. The shares were sold at an average price of $205.31, for a transaction totalling $545,919.29. Following the completion of the sale, the vice president now directly owns 27,936 shares of the company's stock, valued at $5,735,540.16. Learn More on John Adam Zangerle's trading history.

Who are STERIS's active insiders?

STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (President, CEO & Director), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.

Are insiders buying or selling shares of STERIS?

In the last twelve months, insiders at the medical equipment provider sold shares 6 times. They sold a total of 33,249 shares worth more than $8,040,382.08. The most recent insider tranaction occured on November, 25th when SVP Cary L Majors sold 1,682 shares worth more than $365,532.24. Insiders at STERIS own 1.1% of the company. Learn More about insider trades at STERIS.

Information on this page was last updated on 11/25/2024.

John Adam Zangerle Insider Trading History at STERIS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2022Sell2,659$205.31$545,919.2927,936View SEC Filing Icon  
4/20/2022Sell8,000$255.48$2,043,840.0031,023View SEC Filing Icon  
9/14/2020Sell2,000$167.00$334,000.00View SEC Filing Icon  
10/4/2019Sell1,000$142.15$142,150.00
5/31/2019Sell1,500$131.77$197,655.00View SEC Filing Icon  
1/25/2019Sell3,000$115.00$345,000.0033,796View SEC Filing Icon  
1/11/2019Sell1,750$110.00$192,500.0032,546View SEC Filing Icon  
11/14/2017Sell3,650$88.00$321,200.00View SEC Filing Icon  
5/3/2017Sell3,150$75.00$236,250.0026,639View SEC Filing Icon  
12/13/2016Sell3,100$69.00$213,900.0026,589View SEC Filing Icon  
11/15/2016Sell2,200$67.00$147,400.0026,166View SEC Filing Icon  
6/2/2014Sell2,000$53.45$106,900.00View SEC Filing Icon  
See Full Table

John Adam Zangerle Buying and Selling Activity at STERIS

This chart shows John Adam Zangerle's buying and selling at STERIS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STERIS Company Overview

STERIS logo
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Read More

Today's Range

Now: $207.49
Low: $203.70
High: $208.56

50 Day Range

MA: $218.92
Low: $204.34
High: $228.21

2 Week Range

Now: $207.49
Low: $197.82
High: $248.24

Volume

1,251,274 shs

Average Volume

505,471 shs

Market Capitalization

$20.48 billion

P/E Ratio

47.37

Dividend Yield

1.08%

Beta

0.83
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.